We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+30.88%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.73B
AUM Growth
+$507M
(+23%)
Cap. Flow
+$31.1M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
21.62%
Holding
273
New
30
Increased
132
Reduced
65
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mercury Systems
MRCY
|
+$22.2M |
| 2 |
ESCO Technologies
ESE
|
+$15.2M |
| 3 |
Onto Innovation
ONTO
|
+$13.9M |
| 4 |
Mirum Pharmaceuticals
MIRM
|
+$13.6M |
| 5 |
CWAN
Clearwater Analytics
CWAN
|
+$13.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$52.2M |
| 2 |
Insmed
INSM
|
+$44.4M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
+$35.5M |
| 4 |
Carpenter Technology
CRS
|
+$21.7M |
| 5 |
Chart Industries
GTLS
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.35% |
| 2 | Healthcare | 21.4% |
| 3 | Industrials | 18.56% |
| 4 | Financials | 13.16% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
251
DELISTED
Blueprint Medicines
BPMC
| – | – |
-401,644
| Closed | -$35.5M |
|
252
Comstock Resources
CRK
$3.92B
| – | – |
-7,755
| Closed | -$158K |
|
253
CVRx
CVRX
$130M
| – | – |
-590,850
| Closed | -$7.23M |
|
254
Elastic
ESTC
$6.4B
| – | – |
-2,144
| Closed | -$191K |
|
255
Installed Building Products
IBP
$6.16B
| – | – |
-13,476
| Closed | -$2.31M |
|
256
Immunovant
IMVT
$8.27B
| – | – |
-9,246
| Closed | -$158K |
|
257
Jack in the Box
JACK
$286M
| – | – |
-5,663
| Closed | -$154K |
|
258
Lantheus
LNTH
$7B
| – | – |
-3,767
| Closed | -$368K |
|
|
LNW
259
DELISTED
Light & Wonder
LNW
| – | – |
-5,327
| Closed | -$461K |
|
|
ONT
260
Onterris Inc
ONT
$756M
| – | – |
-12,371
| Closed | -$176K |
|
261
NeoGenomics
NEO
$1.9B
| – | – |
-855,688
| Closed | -$8.12M |
|
262
Northern Oil and Gas
NOG
$2.31B
| – | – |
-531
| Closed | -$16.1K |
|
263
Quanterix
QTRX
$182M
| – | – |
-25,542
| Closed | -$166K |
|
264
SentinelOne
S
$6.71B
| – | – |
-13,043
| Closed | -$237K |
|
265
Silicon Laboratories
SLAB
$7.17B
| – | – |
-5,296
| Closed | -$596K |
|
266
SharkNinja
SN
$21.9B
| – | – |
-2,814
| Closed | -$235K |
|
267
Sarepta Therapeutics
SRPT
$1.82B
| – | – |
-19,830
| Closed | -$1.27M |
|
268
Stewart Information Services
STC
$2.19B
| – | – |
-70,507
| Closed | -$5.03M |
|
269
Tidewater
TDW
$3.77B
| – | – |
-6,478
| Closed | -$274K |
|
270
Teradyne
TER
$50.5B
| – | – |
-2,814
| Closed | -$232K |
|
271
Unity
U
$12.7B
| – | – |
-19,516
| Closed | -$382K |
|
272
Select Water Solutions
WTTR
$2.53B
| – | – |
-49,148
| Closed | -$516K |
|
273
Expro Ltd
XPRO
$1.87B
| – | – |
-2,682
| Closed | -$26.7K |
|
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, Emerald Advisers held 273 positions worth $2.73B, up 23% from $2.22B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Emerald Advisers's Q2 2025 filing shows 30 new, 132 increased, 65 reduced and 25 closed positions. Its largest new stake was Mercury Systems: 456,713 shares worth $24.6M. The largest sale was FTAI Aviation, an estimated $52.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- Emerald Advisers's largest Q2 2025 buy was Mercury Systems: 456,713 shares worth $24.6M.
- Emerald Advisers added most to Clearwater Analytics in Q2 2025, an estimated $13.2M increase.
- Emerald Advisers's biggest Q2 2025 reduction was FTAI Aviation, cutting an estimated $52.2M.
- Emerald Advisers fully exited Blueprint Medicines in Q2 2025, selling an estimated $35.5M.
- Emerald Advisers's ten largest holdings make up 22% of its $2.73B portfolio in Q2 2025.
- Emerald Advisers opened 30 new positions and closed 25 in Q2 2025.
- Emerald Advisers's portfolio value rose 23% quarter-over-quarter to $2.73B.
Based on Emerald Advisers's 13F filing for Q2 2025, filed 4 Aug 2025.